BAM
BN
Post-earnings, the analysts come out swinging
Brookfield just did what public companies are supposed to do in earnings season: beat expectations, talk up growth, and then immediately get the stock twisted around by analysts with calculators and strong opinions.
The company reported Q1 earnings of 66 cents a share, edging past the 65-cent estimate. Revenue also came in way above the street’s forecast, thanks to a mix of asset management growth, wealth solutions scaling, and steady cash flow from its operating businesses.
The real headline: the target math got a refresh
But the part investors will actually care about is what happened after the print. RBC Capital’s Bart Dziarski kept an Outperform rating on BN and nudged the price target down from $63 to $61. Scotiabank’s Mario Saric stayed at Sector Outperform and lifted his target from $48.50 to $53.
That’s basically Wall Street saying: “We still like the story, but let’s maybe not act like every quarter is going to moonshot forever.”
Buybacks: the corporate version of backing up the truck
Brookfield also said it repurchased more than $1 billion of shares year-to-date in the open market, including $470 million of BN shares and $575 million of BAM shares. That’s a pretty loud signal that management thinks the stock isn’t exactly expensive.
Still, the market didn’t throw a parade. BN fell 4.4% to $45.50 on Friday, which is a reminder that even a solid beat can get lost in the “okay, now prove it again” phase of earnings season.
Big picture: Brookfield’s business is still humming, but the analyst notes suggest investors are moving from hype mode into “show me the next leg” mode.